Some Big Phar­mas stepped up their game on da­ta trans­paren­cy — but which flunked the test?

The non­prof­it Bioethics In­ter­na­tion­al has come out with their lat­est score­card on da­ta trans­paren­cy among the big bio­phar­mas in the in­dus­try — flag­ging a few stand­outs while spot­light­ing some lag­gards who are con­tin­u­ing to un­der­per­form.

Now in its third year, the non­prof­it cre­at­ed a new set of stan­dards with Yale School of Med­i­cine and Stan­ford Law School to eval­u­ate the track record on tri­al reg­is­tra­tion, re­sults re­port­ing, pub­li­ca­tion and da­ta-shar­ing prac­tice.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER